# Verrica Pharmaceuticals Inc.: Form 8-K, filed Jun 12, 2025

- Company: [Verrica Pharmaceuticals Inc.](/companies/vrca.md) (CIK 1660334)
- Form: 8-K
- Filed: 2025-06-12
- Accepted by EDGAR: Jun 12, 2025, 16:27 ET
- Period: 2025-06-10
- Accession: 0001193125-25-139959
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1660334/000119312525139959/d949783d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1660334/000119312525139959/

## Items reported

- Item 1.01: Entry into a material agreement

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1660334/000119312525139959/d949783d8k.htm

Filed Jun 12, 2025.
Source: SEC EDGAR, the filing index for accession 0001193125-25-139959. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.